Age-based prognosis in oral tongue squamous cell carcinoma patients: A systematic review and meta-analysis

Abstract Background The prognostic significance of younger age in oral tongue squamous cell carcinoma (OTSCC) remains uncertain because age definitions, treatment strategies, outcome definitions, and adjustment methods vary substantially across studies. Objective To evaluate the prognostic significance of younger age in OTSCC by separately synthesising adjusted survival outcomes and event-based recurrence outcomes. Methods A systematic review and meta-analysis was conducted in accordance with PRISMA 2020. Fifty studies were retained after detailed original-paper eligibility assessment. Random-effects models using restricted maximum-likelihood estimation and Hartung-Knapp confidence intervals were used for adjusted survival and recurrence syntheses. Nodal outcomes were synthesised narratively because endpoint definitions were not sufficiently comparable. Results Fourteen studies contributed to the main quantitative meta-analyses. Younger patients had improved adjusted overall survival (aHR 0.59, 95% CI 0.54–0.64; I²=0%), while adjusted disease-specific/cancer-specific survival (aHR 0.89, 95% CI 0.58–1.36; I²=0%) and disease-free/progression-free survival (aHR 0.71, 95% CI 0.22–2.30; I²=0%) did not differ significantly. Overall recurrence was higher in younger patients (RR 1.52, 95% CI 1.22–1.88; I²=0%). Local recurrence showed an elevated but non-significant pooled estimate (RR 1.61, 95% CI 0.85–3.07; I²=65.4%). Sensitivity analyses were directionally consistent, although several surgery-first estimates were imprecise. Conclusions Younger age alone does not appear to be an independent adverse prognostic factor for survival in OTSCC. The higher overall recurrence risk warrants attention, but the heterogeneous local recurrence evidence and unadjusted event-based analyses require cautious interpretation. Treatment should remain guided primarily by tumour stage and pathological risk factors rather than chronological age alone.

Authors

Institutions

Publication Details

Journal
BMC Oral Health
Published
2026-09-25
DOI
https://doi.org/10.1186/s12903-026-10026-w
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Age-based prognosis in oral tongue squamous cell carcinoma patients: A systematic review and meta-analysis

Awais Wahab, Amr Elseragy, Iina Lammela, Tuula Salo
BMC Oral Health
Head and Neck Cancer Studies
article

Age-based prognosis in oral tongue squamous cell carcinoma patients: A systematic review and meta-analysis

Awais Wahab, Amr Elseragy, Iina Lammela, Tuula Salo
article en

Abstract

Abstract Background The prognostic significance of younger age in oral tongue squamous cell carcinoma (OTSCC) remains uncertain because age definitions, treatment strategies, outcome definitions, and adjustment methods vary substantially across studies. Objective To evaluate the prognostic significance of younger age in OTSCC by separately synthesising adjusted survival outcomes and event-based recurrence outcomes. Methods A systematic review and meta-analysis was conducted in accordance with PRISMA 2020. Fifty studies were retained after detailed original-paper eligibility assessment. Random-effects models using restricted maximum-likelihood estimation and Hartung-Knapp confidence intervals were used for adjusted survival and recurrence syntheses. Nodal outcomes were synthesised narratively because endpoint definitions were not sufficiently comparable. Results Fourteen studies contributed to the main quantitative meta-analyses. Younger patients had improved adjusted overall survival (aHR 0.59, 95% CI 0.54–0.64; I²=0%), while adjusted disease-specific/cancer-specific survival (aHR 0.89, 95% CI 0.58–1.36; I²=0%) and disease-free/progression-free survival (aHR 0.71, 95% CI 0.22–2.30; I²=0%) did not differ significantly. Overall recurrence was higher in younger patients (RR 1.52, 95% CI 1.22–1.88; I²=0%). Local recurrence showed an elevated but non-significant pooled estimate (RR 1.61, 95% CI 0.85–3.07; I²=65.4%). Sensitivity analyses were directionally consistent, although several surgery-first estimates were imprecise. Conclusions Younger age alone does not appear to be an independent adverse prognostic factor for survival in OTSCC. The higher overall recurrence risk warrants attention, but the heterogeneous local recurrence evidence and unadjusted event-based analyses require cautious interpretation. Treatment should remain guided primarily by tumour stage and pathological risk factors rather than chronological age alone.

BMC Oral Health
University of Helsinki (FI), Oulu University Hospital (FI), Helsinki University Hospital (FI), Hospital District of Helsinki and Uusimaa (FI), University of Oulu (FI)
Good health and well-being
Openalex Percentile: Top 10%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.